National
this article is about a single country
Galderma, le discret empire suisse du botox
La capitalisation de la société dermatologique a doublé depuis son entrée en bourse en 2024. Elle profite de la banalisation des injections de toxine botulique, un pactole mondial qui devrait atteindre 13 milliards de dollars cette année, malgré des scandales récurrents.
Countries concerned
Read the original article — Le Monde — International
Items are taken from public sources: only the headline and summary appear here, the full article stays on the source’s own site.
This subject deserves more than a headline
Comments are just above. To go further: a debate on the forum, or a signed op-ed.A question the subject raises for you. Debated together.
Open a debateA stand the subject inspires in you. A signed text, published on its own.
Write an op-edNo tribune written in reply yet.
No comments yet — be the first
Sign in to comment. Sign in